A Study of Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

Clinical trial NCT02386553 · COMPLETED

Trial details

NCT number: NCT02386553
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Spinal Muscular Atrophy

Start date: 2015-05-18
Primary completion: 2024-12-17
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.